improving Oncology exploration with Integrated KRAS Assay expert services and RAS Assays
In the rapidly evolving subject of oncology investigate, precise and effective mutation screening is important for developing specific therapies. The KRAS providers Platform plays a pivotal part With this landscape by featuring complete methods for KRAS mutation profiling and Assessment. KRAS mutations, present in approximately ninety five% of RAS-